• GDC-0994: ERK1/2 Inhibition Workflow

  2026-09-02

  GDC-0994 is a potent, selective ERK1/2 inhibitor for testing MAP kinase dependence in mutant RAS/BRAF cancer models and ERK-linked cholestasis assays. This practical guide covers compound preparation, phosphoprotein validation, zebrafish endpoints, dose optimization, and troubleshooting across both applications.

• CDK4/6–BET Synergy in Pancreatic Cancer

  2026-09-01

  Gu et al. show that combining the CDK4/6 inhibitor palbociclib with the BET inhibitor JQ1 can counter a major limitation of CDK4/6 blockade in pancreatic ductal adenocarcinoma: increased migration, invasion, and epithelial-to-mesenchymal transition. The study links this synergy to coordinated regulation of GSK3β-mediated Wnt/β-catenin signaling and TGF-β/Smad crosstalk, providing a mechanistic rationale for combination treatment.

• Losartan and AT1 Signaling: From Vessels to Tumors

  2026-09-01

  Losartan is an angiotensin II receptor antagonist used to dissect AT1 signaling in vascular and stromal biology. This article connects hypertension research with tumor-microenvironment assay design while clarifying what recent ARB evidence does—and does not—demonstrate.

• Glabridin–Gold(I) Complex Reprograms Tumor Immunity

  2026-08-31

  The reference study introduces complex 6d, which combines an N-heterocyclic carbene gold(I) center with glabridin to coordinate TrxR and MAPK pathway modulation. In liver cancer models, this design strengthens dendritic-cell activity while reducing several immunosuppressive cell populations, providing a mechanistic basis for combination strategies with cancer immunotherapy.

• Y-27632 dihydrochloride in Gut–Brain Assays

  2026-08-31

  Discover how Y-27632 dihydrochloride can function not only as a ROCK inhibitor for cell survival, but also as a mechanistic control in gut-to-vagus α-synuclein studies. This article translates a novel organoid–neuron model into practical assay-design decisions while separating established evidence from testable hypotheses.

• Quercetin, Hippo Signaling, and Cataract Protection

  2026-08-30

  The reference study combines network pharmacology with mouse and lens epithelial-cell experiments to investigate how quercetin protects against cataract-associated damage. Its results link quercetin to reduced oxidative stress, improved epithelial-cell survival, and suppression of Hippo pathway activity, while α-hederin reverses several of these effects.

• Live-Dead Cell Staining Kit: 5 Lab Scenarios

  2026-08-29

  This scenario-driven guide explains how the Live-Dead Cell Staining Kit, SKU K2081, supports defensible cell viability, cytotoxicity, and membrane-integrity measurements. It connects Calcein-AM Propidium Iodide staining principles with practical controls, imaging, flow cytometry, biomaterial testing, and vendor-selection criteria.

• Direct Mouse Genotyping Kit Plus for SCA3 Models

  2026-08-28

  The Direct Mouse Genotyping Kit Plus enables direct PCR from mouse-tissue lysates with a PCR master mix with dye reagents. It can streamline genotype confirmation for transgene detection in mice, gene knockout validation, and animal colony genetic screening, while remaining distinct from phenotyping or clinical testing.

• DiI (DiIC18(3)) Membrane Probe Guide

  2026-08-28

  DiI (DiIC18(3)) is a water-insoluble, lipophilic fluorescent dye for orange-red plasma membrane labeling in live or fixed cells and tissues. It is appropriate for membrane tracking, neuronal tracing, migration, adhesion, and related workflows, but not for aqueous-only staining or organelle-specific labeling.

• JC-1 Mitochondrial Membrane Potential Assay

  2026-08-27

  Learn how the JC-1 Mitochondrial Membrane Potential Assay Kit, SKU K2002, helps resolve inconsistent viability and apoptosis data by measuring potential-dependent red and green fluorescence. This scenario-based guide covers assay design, controls, protocol handling, interpretation, and practical kit selection.

• Losartan Workflows for AT1 Signaling Research

  2026-08-27

  Losartan provides a selective pharmacological handle for connecting angiotensin II signaling pathway activity with vascular remodeling, blood-pressure phenotypes, and stromal biology. This workflow-focused guide shows how to optimize cell, tissue, animal, and tumor-microenvironment assays while separating established evidence from practical starting conditions.

• Lactate-GPR81/FARP1 and Insulin-Independent Glucose Uptake

  2026-08-26

  The 2026 Cell Research study identifies L-lactate as an insulin-independent regulator of skeletal-muscle glucose uptake and defines a GPR81–FARP1–RAC1 pathway that promotes GLUT4 translocation. Its combination of genetic, pharmacological, metabolic, exercise, and human genetic evidence provides a mechanistic framework for studying glucose control when insulin action is impaired.

• JC-1 Mitochondrial Membrane Potential Assay Kit Guide

  2026-08-26

  Use the JC-1 Mitochondrial Membrane Potential Assay Kit to connect mitochondrial depolarization with apoptosis and therapeutic response. This guide presents a mechanism-first workflow for interpreting ΔΨm data in hypoxia-activated cancer therapy studies without overstating what fluorescence alone can prove.

• Digestive Transformation of Ashwagandha Bioactives

  2026-08-25

  This 2026 study combines simulated gastrointestinal digestion, LC–MS/MS profiling, untargeted metabolomics, and molecular networking to determine how Withania somnifera leaf and root constituents change before absorption. Its central finding is that transformation is compound- and tissue-dependent: withaferin A and withanoside IV were labile, whereas withanolide A and many root-extract withanolides were comparatively stable.

• Müller Cell PEDF Controls Retinal Neuron Survival

  2026-08-25

  The reference study identifies a Müller cell-mediated pathway in which opposing angiopoietin signals regulate Tie-2–PI3K/Akt activity, PEDF production, and retinal neuronal survival. Its co-culture, hypoxia, and loss-of-function experiments distinguish indirect glial control from direct neuronal responses and provide a mechanistic framework for studying retinal neurovascular injury.

8165 records 1/545 page Next 12345 下5页 Last page